Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 71 sources its claims cite is checked for support yet.

Chitosan Hemostatic Dressings: Properties and Surgical Applications

Open access
Cassano, Roberta, Perri, Paolo, Scarcello, Edoardo, Piro, Paolo, Sole, Roberta, Curcio, Federica, Trombino, Sonia · 2024 · Polymers

Abstract

Wounds caused by trauma and/or surgery represent a significant challenge in contemporary medical practice, requiring innovative approaches to promote optimal healing and reduce the risk of bleeding and complications resulting from it. In this context, chitosan, a natural polysaccharide derived from chitin, represents an ideal material for the study and application of medical devices, in the form of dressings, in wound management for pre- and/or post-operative wounds due to its ability to induce hemostasis and its high biocompatibility with biological tissues. The aim of this work was to discuss the structural characteristics, properties and application of chitosan-based hemostatic dressings in hemostatic processes resulting from pre- or post-surgical approaches.

Overview

CoChat Summary

TL;DR

This review discusses chitosan-based hemostatic dressings, their structural and chemical properties, mechanisms of hemostasis, and surgical applications. It reports that chitosan dressings can rapidly control bleeding and reduce complications, though no single ideal product exists and evidence includes preliminary and animal studies.

Key findings

  • Chitosan’s cationic amine groups interact electrostatically with negatively charged erythrocytes and platelets, causing agglutination, platelet adhesion/aggregation, and formation of a mucoadhesive barrier; a high degree of deacetylation promotes erythrocyte and platelet aggregation.
  • Reviewed commercial dressings include HemCon (lyophilized chitosan acetate), Celox (chitosan granules/flakes), Axiostat (highly porous chitosan matrix; strong blood clot in 2 to 3 min), TraumaStat (chitosan, silicon dioxide, polyethylene; 20 μm fibers), and ChitoSeal (chitosan/cellulose; ambulation after 3 to 4 h vs 6 h with manual compression).
  • In a 60-patient hemodialysis study, HemCon achieved hemostasis at the arterial access site within the first two minutes in 76.6% of cases, while conventional dressing averaged 10 to 12 min. In 28 albino Wistar rats with femoral artery injury, AHA and Celox provided effective hemostasis within 2 min after application (p < 0.001). In 120 patients undergoing manual compression closure with Axiostat, primary technical success was 91.7%, adequate hemostasis after around 8.9 (±3.9) min, ambulation after 462 (±199) min, and bleeding-related complications in 5.8%.
  • Axiostat in dental extraction in cardiac patients on antiplatelet therapy reduced bleeding time and post-operative pain/comorbid conditions (Rajendra et al.). The review concludes chitosan dressings reduce mean time to hemostasis and adverse events, but no ideal product exists; nanotechnology and composite materials are future directions.

Methods

  • Design: narrative review of chitosan-based hemostatic dressings, focusing on structural characteristics, properties, and pre-/post-surgical applications.
  • Data/sample: published literature and commercially available chitosan dressings (HemCon, Celox, Axiostat, TraumaStat, ChitoSeal, etc.), including cited clinical and animal studies (e.g., 60 hemodialysis patients, 28 rats, 120 endovascular patients, dental extraction study).
  • Main analysis: descriptive synthesis of mechanisms, product characteristics, application procedures, and reported outcomes; no systematic search strategy or meta-analysis described.

Limitations

  • The paper does not state a dedicated limitations section. It notes that no specific hemostatic product on the market can be considered ideal.
  • Evident from the text: as a narrative review, it lacks a described systematic search strategy or inclusion/exclusion criteria, and several cited clinical studies are preliminary or use small samples/animal models (e.g., Minici et al. preliminary clinical experience; Binnetoglu et al. rat femoral artery model).
  • Some cited clinical evidence is limited in size or scope (e.g., 60 patients, 120 patients, 28 rats), which restricts generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/polym16131770

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Schematic representation of the application and the hemostatic process activated by HemCon dressing.
Figure 1 Schematic representation of the application and the hemostatic process activated by HemCon dressing.CC BY · PubMed Central
Figure 2 Axiostat dressing use and application.
Figure 2 Axiostat dressing use and application.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 61 Not checked · 28 Own results and interpretations

40 more claims

Create a free account to see all 89 claims and to verify the 71 references still open.

See all claims — free account
  • It may state two separate claims as one. 42
  • Probably not a substantial claim. 3
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Research works printed but not linked: 2

  1. Sinha, 2017, Chitosan based Axiostat dental dressing following extraction in cardiac patients under antiplatelet therapy, Int. J. Oral. Health Med. Res., 3, 65
  2. Vallabh, K. (2013). Acute upper limb ischemia. Vascular Emergencies: Expert Management for the Emergency Physician, Cambridge University Press.

Cited by

See all 77

Metadata

Authors
Cassano, R., Perri, P., Scarcello, E., Piro, P., Sole, R., Curcio, F., & Trombino, S.
Affiliations
  • University of Calabria (IT)
  • Ospedale Annunziata di Cosenza (IT)
Corresponding author
  • Curcio, Federica
  • Trombino, Sonia
Venue
Polymers
Publisher
MDPI AG
Published
2024-06-22
Volume
16
Issue
13
Pages
1770
ISSN
2073-4360 (ISSN-L)
OpenAlex
W4399979977
Cited by
77
References
72
Citations by year
2026: 41 · 2025: 33 · 2024: 3
FWCI
5.14
Type
journal article
Language
en
Open access
Locations
  • Polymers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archive of Doctoral Theses and Digital Collections (University of Calabria) (submittedVersion)
Funders
  • Department of Pharmacy and Health and Nutrition Sciences Department of Excellence (L. 232/2016)
  • Development and Industrialization of Innovative Drugs for Personalized Molecular Therapy PA.CRO.DE (L. 232/2016)
Topics
  • Health Sciences › Medicine › Hematology › Hemostasis and retained surgical items
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Health Sciences › Medicine › Surgery › Surgical Sutures and Adhesives
Keywords
chitosan, hemostatic dressings, wound healing, hemostasis, surgical wounds, postoperative wound care, biocompatibility, natural polysaccharides, wound dressings

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.